These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1350733)

  • 21. Rilmenidine and vigilance. Review of clinical studies.
    Mahieux F
    Am J Med; 1989 Sep; 87(3C):67S-72S. PubMed ID: 2571296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Double-blind controlled study of rilmenidine versus hydrochlorothiazide in mild hypertension: clinical and renal haemodynamic evaluation.
    Licata G; Scaglione R; Guillet C; Capuana G; Parrinello G; Indovina A; Lipari R; Mazzola G; Merlino G
    J Hum Hypertens; 1993 Apr; 7(2):153-7. PubMed ID: 8510088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Multicenter, double-blind study comparing rilmenidine 1 mg and hydrochlorothiazide 25 mg in 244 patients].
    Fiorentini C; Guillet C; Guazzi M
    Arch Mal Coeur Vaiss; 1989 Dec; 82 Spec No 5():39-46. PubMed ID: 2517008
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Imidazoline receptors. A new concept in central regulation of the arterial blood pressure.
    Bousquet P; Feldman J; Tibirica E; Bricca G; Greney H; Dontenwill M; Stutzmann J; Belcourt A
    Am J Hypertens; 1992 Apr; 5(4 Pt 2):47S-50S. PubMed ID: 1350728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative effects of rilmenidine and atenolol on tests of autonomic function and mental and dynamic exercise in patients with essential hypertension.
    Panfilov V; Morris AD; Donnelly R; Reid JL
    J Cardiovasc Pharmacol; 1995; 26 Suppl 2():S44-7. PubMed ID: 8642805
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effects of rilmenidine on the central nervous system and kidney].
    Fillastre JP
    Arch Mal Coeur Vaiss; 1989 Dec; 82 Spec No 5():19-23. PubMed ID: 2517005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Rilmenidine sympatholytic activity preserves mental and orthostatic sympathetic response and epinephrine secretion].
    Esler M; Lux A; Jennings G; Hastings J; Socratous F; Lambert G
    Arch Mal Coeur Vaiss; 2004; 97(7-8):786-92. PubMed ID: 15506067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of rilmenidine, a selective I1 imidazoline receptor binding agent in diabetic hypertensive patients.
    Dupuy O; Bauduceau B; Mayaudon H
    Am J Hypertens; 2000 Jun; 13(6 Pt 2):123S-126S. PubMed ID: 10921531
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effects of rilmenidine on arterial parameters in essential arterial hypertension].
    Pannier B; Safar M
    Arch Mal Coeur Vaiss; 1989 Dec; 82 Spec No 5():47-51. PubMed ID: 2517009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Centrally acting antihypertensive agents: an update.
    Sica DA
    J Clin Hypertens (Greenwich); 2007 May; 9(5):399-405. PubMed ID: 17485976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rilmenidine: a clinical overview.
    Reid JL
    Am J Hypertens; 2000 Jun; 13(6 Pt 2):106S-111S. PubMed ID: 10921529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Remodelling of the heart in DOCA-salt hypertensive rats by propranolol and by an alpha-2 agonist, rilmenidine.
    Callens-el Amrani F; Paolaggi F; Swynghedauw B
    J Hypertens; 1989 Dec; 7(12):947-54. PubMed ID: 2576430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced hemodynamic responses to physical and mental stress under low-dose rilmenidine in healthy subjects.
    Teixeira de Castro RR; Tibiriçá E; de Oliveira MA; Moreira PB; Catelli MF; Rocha NN; Nóbrega AC
    Cardiovasc Drugs Ther; 2006 Apr; 20(2):129-34. PubMed ID: 16761192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic treatment with rilmenidine in spontaneously hypertensive rats: differences between two schedules of administration.
    Monassier L; Greney H; Thomas L; Bousquet P
    J Cardiovasc Pharmacol; 2004 Mar; 43(3):394-401. PubMed ID: 15076223
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Noninvasive study of cardiac structure and function after rilmenidine for essential hypertension.
    N'guyen van Cao A; Levy B; Slama R
    Am J Cardiol; 1988 Feb; 61(7):72D-75D. PubMed ID: 2894163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and tolerability of rilmenidine compared with isradipine in hypertensive patients with features of metabolic syndrome.
    Widimský J; Sirotiaková J
    Curr Med Res Opin; 2006 Jul; 22(7):1287-94. PubMed ID: 16834827
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Are centrally acting imidazoline agents appropriate therapy for renovascular hypertension?
    Head GA; Burke SL
    Ann N Y Acad Sci; 2003 Dec; 1009():234-43. PubMed ID: 15028593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rilmenidine: a novel antihypertensive agent.
    Safar ME
    Am J Med; 1989 Sep; 87(3C):24S-29S. PubMed ID: 2571292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of rilmenidine in elderly patients--comparison with hydrochlorothiazide. The Belgian Multicentre Study Group.
    Pelemans W; Verhaeghe J; Creytens G; Coupez G; Van Dessel A; Opsomer M; Corcoran C
    Am J Cardiol; 1994 Dec; 74(13):51A-57A. PubMed ID: 7998586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effects of rilmenidine on rats made insulin resistant and hypertensive by a high fructose diet].
    Berthault MF; Morin J; Dubar M; Ktorza A; Ferré P; Pénicaud L
    Arch Mal Coeur Vaiss; 1996 Aug; 89(8):1103-6. PubMed ID: 8949387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.